Anti-Viral Drugs Market with Current Trends Analysis, 2016-2026 Anti-Viral Drugs Market with Current Trends Analys | Page 4

Report
Description
Report Description
Anti-viral Drugs Market: Drivers and Restraints
As of October 2013, according to WHO, there were around 35.3 Mn people globally,
infected with HIV. Therefore, increased viral infection incidences is one of the important
factors that drives the anti-viral drugs market growth. Because of the solid R&D activities,
newer and advanced treatments and formulations, such as vaccines, combination
therapy and others, are being introduced in the market. Hence, strong R&D is one of the
crucial factors in the anti-viral drugs market growth. On the other hand, high risk of
failure, high cost of R&D and therapy, and government austerity are some of threats
expected to hinder the growth of market. These are some factors anticipated to fuel
growth of global anti-viral drugs market within the forecast period of 2016-2026.
However, increasing usage of natural products and high cost of developing drugs are the
key challenges faced by the market.
Anti-viral Drugs Market: Segmentation
The global anti-viral drugs market is classified on the basis of product type, end user and
geography.
Based on product type, the global anti-viral drugs market is segmented into the
following:
• Hepatitis-C antivirals

• HIV antivirals